Why is Medicamen Biotec falling/rising?

As of 11-Sep, Medicamen Biotech Ltd's stock price is currently at Rs 345.00, reflecting a decrease of Rs 3.35, or 0.96%. The stock has underperformed today, touching an intraday low of Rs 340.6, which is only 1.45% away from its 52-week low. It is also trading below all key moving averages, indicating a bearish trend. Over the past week, the stock has declined by 0.38%, and it has seen a significant drop of 32.25% year-to-date, contrasting sharply with the Sensex, which has gained 4.36% in the same period. Additionally, there has been a notable decline in investor participation, with delivery volume falling by 8.72% against the five-day average, suggesting waning interest in the stock.
Broader Market Context: In the context of the broader market, Medicamen Biotech's performance has been lackluster compared to the Sensex, which has risen by 1.03% over the past week. This underperformance highlights the challenges faced by the company, as it struggles to attract investor confidence amidst a generally positive market environment. The stark contrast in returns, particularly the 68.42% decline over the past three years compared to the Sensex's 36.38% increase, further underscores the difficulties Medicamen Biotech is experiencing relative to the overall market.